MedicinalProductIndication - FHIR Resource (r4)
This MedicinalProductIndication Resource uses the FHIR API standard for access and structure.
Validate an MedicinalProductIndication FHIR Resource (r4)
MedicinalProductIndication Attributes
AttributeField is listTypeDescription
Description: The medication for which this is an indication
FHIR Version: r4
Attribute Type : Reference
Required: N/A
Countability: Array
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"subject": Learn more about the (MedicinalProductIndication) subject FHIR attribute
Description: The disease, symptom or procedure that is the indication for treatment
FHIR Version: r4
Attribute Type : CodeableConcept
Required: N/A
Countability: Singleton
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"diseaseSymptomProcedure": {
"coding": [
{
"system": "http://ema.europa.eu/example/indicationasdisease-symptom-procedure",
"code": "Venousthromboembolismprophylaxis"
}
],
"text": "Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."
}Learn more about the (MedicinalProductIndication) diseaseSymptomProcedure FHIR attribute
Description: The status of the disease or symptom for which the indication applies
FHIR Version: r4
Attribute Type : CodeableConcept
Required: N/A
Countability: Singleton
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"diseaseStatus": Learn more about the (MedicinalProductIndication) diseaseStatus FHIR attribute
Description: Comorbidity (concurrent condition) or co-infection as part of the indication
FHIR Version: r4
Attribute Type : CodeableConcept
Required: N/A
Countability: Array
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"comorbidity": [
{
"coding": [
{
"system": "http://ema.europa.eu/example/comorbidity",
"code": "Hipsurgery"
}
]
}
]Learn more about the (MedicinalProductIndication) comorbidity FHIR attribute
Description: The intended effect, aim or strategy to be achieved by the indication
FHIR Version: r4
Attribute Type : CodeableConcept
Required: N/A
Countability: Singleton
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"intendedEffect": {
"coding": [
{
"system": "http://ema.europa.eu/example/intendedeffect",
"code": "PRYLX"
}
]
}Learn more about the (MedicinalProductIndication) intendedEffect FHIR attribute
Description: Timing or duration information as part of the indication
FHIR Version: r4
Attribute Type : Quantity
Required: N/A
Countability: Singleton
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"duration": Learn more about the (MedicinalProductIndication) duration FHIR attribute
Description: Information about the use of the medicinal product in relation to other therapies described as part of the indication
FHIR Version: r4
Attribute Type : Data Type
Required: N/A
Countability: Array
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"otherTherapy": Learn more about the (MedicinalProductIndication) otherTherapy FHIR attribute
Description: Describe the undesirable effects of the medicinal product
FHIR Version: r4
Attribute Type : Reference
Required: N/A
Countability: Array
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"undesirableEffect": Learn more about the (MedicinalProductIndication) undesirableEffect FHIR attribute
Description: The population group to which this applies
FHIR Version: r4
Attribute Type : Population
Required: N/A
Countability: Array
Flags: N/A
Terminology bindings: N/A
Requirements: N/A
Comments: N/A
Example:
"population": [
{
"ageRange": {
"low": {
"value": 18,
"unit": "a"
}
}
}
]Learn more about the (MedicinalProductIndication) population FHIR attribute
MedicinalProductIndication Example
{
"resourceType": "MedicinalProductIndication",
"id": "example",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div>"
},
"diseaseSymptomProcedure": {
"coding": [
{
"system": "http://ema.europa.eu/example/indicationasdisease-symptom-procedure",
"code": "Venousthromboembolismprophylaxis"
}
],
"text": "Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."
},
"comorbidity": [
{
"coding": [
{
"system": "http://ema.europa.eu/example/comorbidity",
"code": "Hipsurgery"
}
]
}
],
"intendedEffect": {
"coding": [
{
"system": "http://ema.europa.eu/example/intendedeffect",
"code": "PRYLX"
}
]
},
"population": [
{
"ageRange": {
"low": {
"value": 18,
"unit": "a"
}
}
}
]
}MedicinalProductIndication Structure
{
"resourceType" : "MedicinalProductIndication",
// from Resource: id, meta, implicitRules, and language
// from DomainResource: text, contained, extension, and modifierExtension
"subject" : [{ Reference(MedicinalProduct|Medication) }], // The medication for which this is an indication
"diseaseSymptomProcedure" : { CodeableConcept }, // The disease, symptom or procedure that is the indication for treatment
"diseaseStatus" : { CodeableConcept }, // The status of the disease or symptom for which the indication applies
"comorbidity" : [{ CodeableConcept }], // Comorbidity (concurrent condition) or co-infection as part of the indication
"intendedEffect" : { CodeableConcept }, // The intended effect, aim or strategy to be achieved by the indication
"duration" : { Quantity }, // Timing or duration information as part of the indication
"otherTherapy" : [{ // Information about the use of the medicinal product in relation to other therapies described as part of the indication
"therapyRelationshipType" : { CodeableConcept }, // R! The type of relationship between the medicinal product indication or contraindication and another therapy
// medication[x]:
Reference to a specific medication (active substance, medicinal product or class of products) as part of an indication or contraindication. One of these 2:
"medicationCodeableConcept" : { CodeableConcept }
"medicationReference" : { Reference(MedicinalProduct|Medication|Substance|
SubstanceSpecification) }
}],
"undesirableEffect" : [{ Reference(MedicinalProductUndesirableEffect) }], // Describe the undesirable effects of the medicinal product
"population" : [{ Population }] // The population group to which this applies
}
MedicinalProductIndication Search Parameters
The following search parameters can be used to query MedicinalProductIndication resources. Just submit them like so:
https://api.1up.health/fhir/r4/MedicinalProductIndication?query-param=queryvalue| Search Parameter | Field Type | Resource Fields Searched |
|---|---|---|
subject | reference | subject |
